Exposure to infectious biological agents presents serious potential health hazards to staff during many routine cell and tissue culture techniques used in biotechnology and pharmaceutical laboratories. This along with the development of new products from cells and tissues can present health risks to laboratory technicians that handle bacteria, viruses, biological organisms, and the like.
“Remaining in compliance with National Institutes of Health (NIH) recombinant DNA guidelines, the Centers for Disease Control (CDC) and Prevention’s ‘Biosafety in Microbiological and Biomedical Laboratories’
The white paper, titled “Biosafety Review Key to Infection Control” and authored by EH&E, a Needham, Mass.-based environmental engineering and consulting firm, outlines a crucial biosafety review process that has been proven to maintain safety for biotechnology, pharmaceutical and research laboratory professionals.
The paper discusses and provides implementation strategies for the laboratory guidelines from leading government organizations, including:
• Centers for Disease Control and Prevention
• National Institutes of Health
• Occupational Safety and Health Administration (OSHA)
To download the free whitepaper, “Biosafety Review Key to Infection Control,” visit http://www.eheinc.com/
